Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL



Status:Completed
Conditions:Blood Cancer, Lymphoma
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:7/14/2017
Start Date:October 2009
End Date:April 2015

Use our guide to learn which trials are right for you!

Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy With Maintenance Lenalidomide and Rituximab in Relapsed/Refractory CLL/SLL

The purpose of this research is to evaluate a new combination of chemotherapy drugs for
CLL/SLL using the drugs bendamustine (an intravenous chemotherapy drug), rituximab (an
intravenous medication called a monoclonal antibody), and lenalidomide (an anti-cancer pill).

The purpose of this study is to see if giving the chemotherapy pill lenalidomide after
treatment with bendamustine and rituximab is able to prolong the period of time before the
cancer starts growing again and causing symptoms.


Inclusion Criteria:

- Histologically confirmed,CLL/SLL, documented relapsed or refractory disease after at
least one prior chemotherapy regimen.

- In cases of SLL, patients must have at least one bidimensionally measurable lesion at
least ≥1.5 cm measured in one dimension.

- ECOG performance status of 0-2 at study entry

- Laboratory test results within these ranges: ANC <=1500/μL, Platelet count <=
100,000/μL. Patients with ANC <1500/μL or plt <100,000/μL with splenomegaly or
extensive bone marrow involvement as the etiology for their cytopenias are eligible.

- creatinine clearance of >60 mL/min as determined by the Cockcroft-Gault calculation.

- Total bilirubin <= 2X upper limit laboratory normal (ULN). Patients with
non-clinically significant elevations of bilirubin due to Gilbert's disease are not
required to meet these criteria.

- Serum transaminases AST (SGOT) and ALT (SGPT) <=5x ULN, Serum alkaline phosphatase ≤5
X ULN.

- Disease free of prior malignancies for ≥ 2 years with the exception of basal or
squamous cell skin carcinoma, carcinoma "in situ" of the breast or cervix, or
localized prostate cancer (treated definitively with hormone therapy, radiotherapy, or
surgery).

- Patients may have received prior therapy with bendamustine or lenalidomide, but must
not have disease that is refractory to bendamustine or lenalidomide.

- Prior therapy with rituximab is permitted, even in the setting of rituximab refractory
disease.

Exclusion Criteria:

- Has received >5 lines of prior therapy for their disease. Re-treatment with an
identical regimen does not count as a new regimen.

- Any serious medical condition, laboratory abnormality, or psychiatric illness that
would prevent the subject from signing the informed consent form or comply with the
protocol treatment.

- Pregnant or breast feeding females. Lactating females must agree not to breast feed
while taking lenalidomide.

- Prior history or current evidence of central nervous system or leptomeningeal
involvement.

- Use of any other experimental drug or therapy within 28 days of baseline.

- Known hypersensitivity to thalidomide.

- The development of erythema nodosum if characterized by a desquamating rash while
taking thalidomide or similar drugs.

- Known to be positive for HIV or infectious hepatitis, type B or C.
We found this trial at
10
sites
Green Bay, Wisconsin 54301
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
Green Bay, Wisconsin 54301
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
Janesville, Wisconsin 53548
?
mi
from
Janesville, WI
Click here to add this to my saved trials
La Crosse, Wisconsin 54601
?
mi
from
La Crosse, WI
Click here to add this to my saved trials
600 Highland Ave.
Madison, Wisconsin 53792
(608) 263-6400
University of Wisconsin Carbone Cancer Center UW Carbone Cancer Center holds the unique distinction of...
?
mi
from
Madison, WI
Click here to add this to my saved trials
Marshfield, Wisconsin 54449
?
mi
from
Marshfield, WI
Click here to add this to my saved trials
8701 W Watertown Plank Rd
Milwaukee, Wisconsin
(414) 955-8296
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oconomowoc, Wisconsin 53066
?
mi
from
Oconomowoc, WI
Click here to add this to my saved trials
Waukesha, Wisconsin 53188
?
mi
from
Waukesha, WI
Click here to add this to my saved trials
Wisconsin Rapids, Wisconsin 54494
?
mi
from
Wisconsin Rapids, WI
Click here to add this to my saved trials